Tag: Cancer: Misc.
January 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2020. This roundup includes...
Benefits of Psilocybin-Assisted Psychotherapy May Be Lasting
Reductions in anxiety, depression in cancer-related psychiatric distress sustained at 3.2 and 4.5 years
Further Improvements in Survival Seen After Allogeneic Transplant
2003 to 2017 saw reduction in nonrelapse mortality, relapse of cancer, relapse-related and overall mortality
Medical Cannabis May Initially Aid Sleep in Chronic Pain Patients
Compared with placebo, cannabinoids show no improvement in pain scores in adult cancer patients
Cancer Survivors Have Substantial Medical Financial Hardship
Financial sacrifices also reported, with hardship and sacrifices more common in survivors aged 18 to 64
Coronary Artery Disease Risk Down in Survivors of Childhood Cancer
Risk for coronary artery disease significantly decreased for survivors with diagnosis in 80s, 90s versus 70s
FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk
Health care providers should balance the benefits of taking lorcaserin against the potential risks
Alcohol Consumption Levels High in Cancer Patients, Survivors
One in five patients report binge drinking, while one-third exceed moderate drinking levels
Cancer Incidence Up in World Trade Center Responder Cohort
Incidence up for all cancer sites combined and for prostate cancer, thyroid cancer, leukemia
Cancer Mortality Continuing to Drop, With Lung Cancer a Driver
However, decreases in cancer mortality slowed for female breast cancer and CRC, ceased for prostate cancer
